| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Anixa Biosciences, Inc. (ANIX) has 5 insiders with recent SEC Form 4 filings, including 12 buys and 0 sells. ANIX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 987.0K | $3.65M | +14.8K | |
| CEO | 640.8K | $2.37M | +10.0K | |
| CFO | 175.0K | $647.5K | - | |
| Dir | 135.0K | $499.5K | - | |
| Dir | 25.0K | $92.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 11, 2025 | Kumar Amit62 | Chief Executive Officer | Buy | 5,000 | $3.15 | $15,750.00 | +0.9% | +56.7% | -2.5% | |
| Jun 4, 2025 | Kumar Amit62 | Chief Executive Officer | Buy | 10,000 | $2.85 | $28,500.00 | +1.8% | +10.8% | -6.1% | |
| Jan 28, 2025 | Baskies Arnold M48 | Director | Buy | 5,000 | $2.82 | $14,100.00 | +4.3% | 0.0% | +8.2% | |
| Jan 24, 2025 | Titterton Lewis H Jr65 | Director | Buy | 3,000 | $2.94 | $8,820.00 | +0.2% | -4.3% | +15.6% | |
| Jan 22, 2025 | Titterton Lewis H Jr65 | Director | Buy | 2,000 | $3.01 | $6,020.00 | +0.2% | -8.6% | +10.9% | |
| Jan 21, 2025 | Titterton Lewis H Jr65 | Director | Buy | 6,000 | $2.59 | $15,540.00 | +0.7% | -4.3% | +12.8% | |
| Jan 17, 2025 | Titterton Lewis H Jr65 | Director | Buy | 10,000 | $2.57 | $25,700.00 | +1.1% | +12.9% | +32.4% | |
| Jan 15, 2025 | Kumar Amit62 | Chief Executive Officer | Buy | 43,000 | $2.23 | $95,890.00 | +8.3% | +25.0% | +41.2% | |
| Jan 15, 2025 | Catelani Michael70 | President, COO, &CFO | Buy | 9,289 | $2.15 | $19,971.35 | +26.4% | +25.0% | +41.2% | |
| Jul 31, 2024 | Titterton Lewis H Jr65 | Director | Buy | 27,226 | $3.09 | $84,260.16 | +1.5% | +19.0% | -7.8% |